Novavax has appointed Louis Fries III, M.D., as vice president, clinical and medical affairs, and Jane Halpern, Ph.D., as vice president of regulatory affairs. 

Before joining Novavax, Fries was director, global clinical development at GSK Biologicals, North America. Halpern was staff scientist and regulatory affairs specialist at the Vaccine Research Center of the National Institute of Allergy and Infectious Disease, National Institutes of Health.